A tale of two antiviral targets - and the COVID-19 drugs that bind them

Nat Rev Drug Discov. 2022 Jan;21(1):3-5. doi: 10.1038/d41573-021-00202-8.
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / therapeutic use*
  • COVID-19 / immunology
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology
  • Vaccines / immunology

Substances

  • Antiviral Agents
  • Vaccines